sales@scalarmarketresearch.com  |   +1-800-213-5170  (U.S./ Canada Toll-free)  |  REGISTER |  SIGN IN

Home >> Reports >> active pharmaceutical ingredients api market

report

Active Pharmaceutical Ingredient (API) Market, by Manufacturer (Captive, Merchant), Synthesis (Synthetic, Biological), Drug Type (Generics, Branded), Classification (HPAPI, Others), Therapeutic Area (Cardiovascular Disorders, Metabolic Disorders, CNS, Oncology, Musculoskeletal Diseases, NSAIDs, Others) - Global Revenue, Trends, Growth, Share, Size and Forecast to 2022

HC167 October 2016 118 FREE 10% CUSTOMIZATION

Global Active Pharmaceutical Ingredients (API) Market worth USD 154.88 billion in 2016 and expected to reach USD 224.63 billion by 2022, at a CAGR of 6.4% from 2016 to 2022.

The global active pharmaceutical ingredients (API) market report offers in-depth analysis of the market size (revenue), market share, major market segments, different geographic regions, forecast for the next five years, key market players, and premium industry trends. It also focuses on the key drivers, restraints, opportunities and challenges in the active pharmaceutical ingredients (API) market.

KEY BENEFITS OF THE REPORT

  • Thorough understanding of the dynamics influencing the various segments of this market
  • Detailed analysis of the regulatory environment impacting the growth of this market
  • Valuable insights into the key technological and market trends impacting this market

KEY PREMIUM INDUSTRY INSIGHTS

  • The advancements in biologics, increasing local manufacture, the rise in the aging population, and the increasing number of chronic disease are the major drivers for the active pharmaceutical ingredients (API) market.
  • The increasing awareness towards generic drugs, government initiatives, and better market penetration are some of the other factors that will boost the growth of the active pharmaceutical ingredients (API) market during the forecast period.
  • However, the high cost of manufacturing, the regulatory norms, and financial instability are the major restraints for the global active pharmaceutical ingredients (API) market.

RESEARCH METHODOLOGY

The research methodology for Scalar Market Research’s active pharmaceutical ingredients (API) market report utilizes a combination of top-down and bottom-up research formats. Our primary focus on continuous market tracking, rigorous fact-checking, data-triangulation, and multiple layers of quality control ensures high-quality data that can be leveraged for actionable research insights.

To know about the assumptions considered for the study, Download PDF Sample.

MARKET SEGMENTATION

This report analyzes the active pharmaceutical ingredients (API) market by the following segments:

  • Active Pharmaceutical Ingredient (API) Market, by Manufacturer
    • Captive
    • Merchant
  • Active Pharmaceutical Ingredient (API) Market, by Synthesis
    • Synthetic
    • Biological
  • Active Pharmaceutical Ingredient (API) Market, by Drug Type
    • Generic
    • Branded
  • Active Pharmaceutical Ingredient (API) Market, by Classification
    • HPAPI
    • Others
  • Active Pharmaceutical Ingredient (API) Market, by Therapeutic Area
    • Cardiovascular Disorders
    • Metabolic Disorders
    • CNS
    • Oncology
    • Musculoskeletal Diseases
    • NSAIDs
    • Others

KEY MARKET PLAYERS

Key players in the active pharmaceutical ingredients (API) market include:

  • Teva Pharmaceutical Industries, Ltd.
  • Sun Pharmaceutical Industries, Ltd.
  • Dr.Reddy’s Laboratories
  • Aurobindo Pharma Ltd.
  • Mylan N.V.
  • Novartis AG
  • Cambrex Corporation
  • Boehringer Ingelheim GmbH
  • Pfizer, Inc.
  • Lonza Group

GEOGRAPHIC COVERAGE AND ANALYSIS

This granular market research report covers the following geographic regions in great detail:

Active Pharmaceutical Ingredients (API) Market

TRENDING RELATED REPORT

API Contract Manufacturing Market, by Synthesis (Synthetic, Biological), Drug Type (Generics, Branded), Therapeutic Area (Cardiovascular Disorders, Metabolic Disorders, CNS, Oncology, Musculoskeletal Diseases, NSAIDs, Others) - Global Revenue, Trends, Growth, Share, Size and Forecast to 2022


  1. MARKET OVERVIEW
    1. Market Definitions
    2. Research Methodology
    3. Market Segmentation
    4. Assumptions
  2. EXECUTIVE SUMMARY
  3. MARKET DYNAMICS
    1. Drivers
    2. Restraints
    3. Opportunities
    4. Premium Industry Trends
  4. INDUSTRY ANALYSIS
    1. Industry Overview
    2. Regulatory Analysis
  5. ACTIVE PHARMACEUTICAL INGREDIENT MARKET, BY MANUFACTURER
    1. Share Segmentation
    2. Manufacturer
      1. Captive
      2. Merchant
  6. ACTIVE PHARMACEUTICAL INGREDIENT MARKET, BY SYNTHESIS
    1. Share Segmentation
    2. Synthesis
      1. Synthetic
      2. Biological
  7. ACTIVE PHARMACEUTICAL INGREDIENT MARKET, BY DRUG TYPE
    1. Share Segmentation
    2. Drug Type
      1. Generic
      2. Branded
  8. ACTIVE PHARMACEUTICAL INGREDIENT MARKET, BY CLASSIFICATION
    1. Share Segmentation
    2. Classification
      1. HPAPI
      2. Others
  9. ACTIVE PHARMACEUTICAL INGREDIENT MARKET, BY THERAPEUTIC AREA
    1. Share Segmentation
    2. Therapeutic Area
      1. Cardiovascular Disorders
      2. Metabolic Disorders
      3. CNS
      4. Oncology
      5. Musculoskeletal Diseases
      6. NSAIDs
      7. Others
  10. ACTIVE PHARMACEUTICAL INGREDIENT MARKET, BY REGIONS
    1. North America
      1. By Regions
        1. U.S.
        2. Canada
      2. By Manufacturer
      3. By Synthesis
      4. By Drug Type
      5. By Classification
      6. By Therapeutic Area
    2. Europe
      1. By Regions
        1. Germany
        2. U.K.
        3. France
        4. Italy
        5. Rest of Europe
      2. By Manufacturer
      3. By Synthesis
      4. By Drug Type
      5. By Classification
      6. By Therapeutic Area
    3. Asia-Pacific
      1. By Regions
        1. China
        2. India
        3. Russia
        4. Japan
        5. Rest of Asia-Pacific
      2. By Manufacturer
      3. By Synthesis
      4. By Drug Type
      5. By Classification
      6. By Therapeutic Area
    4. Rest of the World
      1. By Regions
        1. Latin America
        2. Middle East & Africa
      2. By Manufacturer
      3. By Synthesis
      4. By Drug Type
      5. By Classification
      6. By Therapeutic Area
  11. COMPETITIVE LANDSCAPE
    1. Market Positioning of Key Players
  12. KEY MARKET PLAYERS
    1. Teva Pharmaceutical Industries, Ltd
      1. Overview
      2. Key Strategies
      3. Recent Developments
    2. Sun Pharmaceutical Industries Ltd
      1. Overview
      2. Key Strategies
      3. Recent Developments
    3. Dr.Reddy’s Laboratories
      1. Overview
      2. Key Strategies
      3. Recent Developments
    4. Aurobindo Pharma Ltd
      1. Overview
      2. Key Strategies
      3. Recent Developments
    5. Mylan N.V
      1. Overview
      2. Key Strategies
      3. Recent Developments
    6. Novartis AG
      1. Overview
      2. Key Strategies
      3. Recent Developments
    7. Cambrex Corporation
      1. Overview
      2. Key Strategies
      3. Recent Developments
    8. Boehringer Ingelheim GmbH
      1. Overview
      2. Key Strategies
      3. Recent Developments
    9. Pfizer, Inc
      1. Overview
      2. Key Strategies
      3. Recent Developments
    10. Lonza Group
      1. Overview
      2. Key Strategies
      3. Recent Developments
  13. SCALAR 360 DEGREE MARKET PERSPECTIVE
  14. APPENDIX

 

 

LIST OF TABLES

Table 1.                Global Active Pharmaceutical Ingredient Market Summary

Table 2.                Global Active Pharmaceutical Ingredients Market Drivers

Table 3.                Global Active Pharmaceutical Ingredient Market Restraints

Table 4.                Application of Guidance to API Manufacturing

Table 5.                Active Pharmaceutical Ingredient Market, By Manufacturer Snapshot

Table 6.                Global Active Pharmaceutical Ingredient Market Size (US$ billion), By Manufacturer (2014 – 2022)

Table 7.                Global Captive API Market Size (US$ billion),By Regions (2014 – 2022)

Table 8.                Global Merchant API Market Size (US$ billion), By Regions (2014 – 2022)

Table 9.                Active Pharmaceutical Ingredient Market, By Synthesis Snapshot

Table 10.              Global Active Pharmaceutical Ingredient Market Size (US$ billion), By Synthesis (2014 – 2022)

Table 11.              Global Active Pharmaceutical Ingredient Market for Synthetic, Market Size (US$ billion) (2014 – 2022)

Table 12.              Global Active Pharmaceutical Ingredient Market for Biological, Market Size (US$ billion) (2014 – 2022)

Table 13.              Active Pharmaceutical Ingredient Market, By Drug Type Snapshot

Table 14.              Global Active Pharmaceutical Ingredient Market Size (US$ billion), By Drug Type (2014 – 2022)

Table 15.              Global Active Pharmaceutical Ingredient Market for Generics, Market Size (US$ billion) (2014 – 2022)

Table 16.              Global Active Pharmaceutical Ingredient Market for Branded, Market Size (US$ billion) (2014 – 2022)

Table 17.              Active Pharmaceutical Ingredient Market, By Classification Snapshot

Table 18.              Global Active Pharmaceutical Ingredient Market Size (US$ billion), By Classification (2014 – 2022)

Table 19.              Global HPAPI Market , Market Size (US$ billion) (2014 – 2022)

Table 20.              Global Active Pharmaceutical Ingredient Market for Other Classification, Market Size (US$ billion) (2014 – 2022)

Table 21.              Active Pharmaceutical Ingredient Market, By Therapeutic Area Snapshot

Table 22.              Global Active Pharmaceutical Ingredient Market Size (US$ billion), By Therapeutic Area (2014 – 2022)

Table 23.              Global Active Pharmaceutical Ingredient Market for Cardiovascular Disorders, Market Size (US$ billion) (2014 – 2022)

Table 24.              Global Active Pharmaceutical Ingredient Market for Metabolic Disorders, Market Size (US$ billion) (2014 – 2022)

Table 25.              Global Active Pharmaceutical Ingredient Market for CNS, Market Size (US$ billion) (2014 – 2022)

Table 26.              Global Active Pharmaceutical Ingredient Market for Oncology, Market Size (US$ billion) (2014 – 2022)

Table 27.              Global Active Pharmaceutical Ingredient Market for Musculoskeletal Diseases, Market Size (US$ billion) (2014 – 2022)

Table 28.              Global Active Pharmaceutical Ingredient Market for NSAIDs, Market Size (US$ billion) (2014 – 2022)

Table 29.              Global Active Pharmaceutical Ingredient Market for Other Diseases, Market Size (US$ billion) (2014 – 2022)

Table 30.              Global Active Pharmaceutical Ingredient Market Size (US$ billion), By Geography (2014 – 2022)

Table 31.              Global Active Pharmaceutical Ingredient Market, Market Size (%), By Major Regions (2014 – 2022)

Table 32.              Active Pharmaceutical Ingredient Market in North America, Market Size (US$ billion) (2014 – 2022)

Table 33.              Active Pharmaceutical Ingredient Market in U.S, Market Size (US$ billion), (2014 – 2022)

Table 34.              Active Pharmaceutical Ingredient Market in Canada, Market Size (US$ billion), (2014 – 2022)

Table 35.              Active Pharmaceutical Ingredient Market in North America, Market Size (US$ billion), By Manufacturer (2014 – 2022)

Table 36.              Active Pharmaceutical Ingredient Market in North America, Market Size (US$ billion), By Synthesis (2014 – 2022)

Table 37.              Active Pharmaceutical Ingredient Market in North America, Market Size (US$ billion), By Drug Type (2014 – 2022)

Table 38.              Active Pharmaceutical Ingredient Market in North America, Market Size (US$ billion), By Classification (2014 – 2022)

Table 39.              Active Pharmaceutical Ingredient Market in North America, Market Size (US$ billion), By Therapeutic Area (2014 – 2022)

Table 40.              Active Pharmaceutical Ingredient Market in Europe, Market Size (US$ billion)

Table 41.              Active Pharmaceutical Ingredient Market in Germany, Market Size (US$ billion), (2014 – 2022)

Table 42.              Active Pharmaceutical Ingredient Market in U.K, Market Size (US$ billion), (2014 – 2022)

Table 43.              Active Pharmaceutical Ingredient Market in France, Market Size (US$ billion), (2014 – 2022)

Table 44.              Active Pharmaceutical Ingredient Market in Italy, Market Size (US$ billion), (2014 – 2022)

Table 45.              Active Pharmaceutical Ingredient Market in Rest of Europe, Market Size (US$ billion), (2014 – 2022)

Table 46.              Active Pharmaceutical Ingredient Market in Europe, Market Size (US$ billion), By Manufacturer (2014 – 2022)

Table 47.              Active Pharmaceutical Ingredient Market in Europe, Market Size (US$ billion), By Synthesis (2014 – 2022)

Table 48.              Active Pharmaceutical Ingredient Market in Europe, Market Size (US$ billion), By Drug Type (2014 – 2022)

Table 49.              Active Pharmaceutical Ingredient Market in Europe, Market Size (US$ billion), By Classification (2014 – 2022)

Table 50.              Active Pharmaceutical Ingredient Market in Europe, Market Size (US$ billion), By Synthesis (2014 – 2022)

Table 51.              Active Pharmaceutical Ingredient Market in Asia-Pacific, Market Size (US$ billion)

Table 52.              Active Pharmaceutical Ingredient Market in China, Market Size (US$ billion), (2014 – 2022)

Table 53.              Active Pharmaceutical Ingredient Market in India, Market Size (US$ billion), (2014 – 2022)

Table 54.              Active Pharmaceutical Ingredient Market in Australia, Market Size (US$ billion), (2014 – 2022)

Table 55.              Active Pharmaceutical Ingredient Market in Japan, Market Size (US$ billion), (2014 – 2022)

Table 56.              Active Pharmaceutical Ingredient Market in Rest of Asia-Pacific, Market Size (US$ billion), (2014 – 2022)

Table 57.              Active Pharmaceutical Ingredient Market in Asia-Pacific, Market Size (US$ billion), By Manufacturer (2014 – 2022)

Table 58.              Active Pharmaceutical Ingredient Market in Asia-Pacific, Market Size (US$ billion), By Synthesis (2014 – 2022)

Table 59.              Active Pharmaceutical Ingredient Market in Asia-Pacific, Market Size (US$ billion), By Drug Type (2014 – 2022)

Table 60.              Active Pharmaceutical Ingredient Market in Asia-Pacific, Market Size (US$ billion), By Classification (2014 – 2022)

Table 61.              Active Pharmaceutical Ingredient Market in Asia-Pacific, Market Size (US$ billion), By Therapeutic Area (2014 – 2022)

Table 62.              Active Pharmaceutical Ingredient Market in Rest of the World (ROW), Market Size (US$ billion) (2014 – 2022)

Table 63.              Active Pharmaceutical Ingredient Market in Latin America, Market Size (US$ billion), (2014 – 2022)

Table 64.              Active Pharmaceutical Ingredient Market in Middle East & Africa, Market Size (US$ billion), (2014 – 2022)

Table 65.              Active Pharmaceutical Ingredient Market in Rest of the World (ROW), Market Size (US$ billion), By Manufacturer (2014 – 2022)

Table 66.              Active Pharmaceutical Ingredient Market in Rest of the World (ROW), Market Size (US$ billion), By Synthesis (2014 – 2022)

Table 67.              Active Pharmaceutical Ingredient Market in Rest of the World (ROW), Market Size (US$ billion), By Drug Type (2014 – 2022)

Table 68.              Active Pharmaceutical Ingredient Market in Rest of the World (ROW), Market Size (US$ billion), By Classification (2014 – 2022)

Table 69.              Active Pharmaceutical Ingredient Market in Rest of the World (ROW), Market Size (US$ billion), By Therapeutic Area (2014 – 2022)

Table 70.              Active Pharmaceutical Ingredient Market, Snapshot

Table 71.              Acronyms

 

LIST OF FIGURES

Figure 1.               Research Methodology

Figure 2.               Market Attractiveness for Active Pharmaceutical Ingredients Manufacturing Set-up

Figure 3.               Global Active Pharmaceutical Ingredient Segment Share (%), By Manufacturer (2016 & 2022)

Figure 4.               Global Active Pharmaceutical Ingredient Market Size (US$ billion), By Manufacturer (2016 & 2022)

Figure 5.               Global Captive API Market Size (US$ billion), By Regions (2016 & 2022)

Figure 6.               Global Merchant API Market Size (US$ billion), By Regions (2016 & 2022)

Figure 7.               Global Active Pharmaceutical Ingredient Market, Segment Share (%), By Synthesis (2016 & 2022)

Figure 8.               Global Active Pharmaceutical Ingredient Market Size (US$ billion), By Synthesis (2016 & 2022)

Figure 9.               Global Active Pharmaceutical Ingredient Market for Synthetic, Market Size (US$ billion) (2016 & 2022)

Figure 10.            Global Active Pharmaceutical Ingredient Market for Biological, Market Size (US$ billion) (2016 & 2022)

Figure 11.            Global Active Pharmaceutical Ingredient Market, Segment Share (%), By Drug Type (2016 & 2022)

Figure 12.            Global Active Pharmaceutical Ingredient Market Size (US$ billion), By Drug Type (2016 & 2022)

Figure 13.            Global Active Pharmaceutical Ingredient Market for Generics, Market Size (US$ billion) (2016 & 2022)

Figure 14.            Global Active Pharmaceutical Ingredient Market for Branded, Market Size (US$ billion) (2016 & 2022)

Figure 15.            Global Active Pharmaceutical Ingredient Market, Segment Share (%), By Classification (2016 & 2022)

Figure 16.            Global Active Pharmaceutical Ingredient Market Size (US$ billion), By Classification (2016 & 2022)

Figure 17.            Global HPAPI, Market Size (US$ billion) (2016 & 2022)

Figure 18.            Global Active Pharmaceutical Ingredient Market for Other Classification, Market Size (US$ billion) (2016 & 2022)

Figure 19.            Global Active Pharmaceutical Ingredient Market, Segment Share (%), By Therapeutic Area (2016 & 2022)

Figure 20.            Global Active Pharmaceutical Ingredient Market Size (US$ billion), By Therapeutic Area (2016 & 2022)

Figure 21.            Global Active Pharmaceutical Ingredient Market for Cardiovascular Disorders, Market Size (US$ billion) (2016 & 2022)

Figure 22.            Global Active Pharmaceutical Ingredient Market for Metabolic Disorders, Market Size (US$ billion) (2016 & 2022)

Figure 23.            Global Active Pharmaceutical Ingredient Market for CNS, Market Size (US$ billion) (2016 & 2022)

Figure 24.            Global Active Pharmaceutical Ingredient Market for Oncology, Market Size (US$ billion) (2016 & 2022)

Figure 25.            Global Active Pharmaceutical Ingredient Market for Musculoskeletal Diseases, Market Size (US$ billion) (2016 & 2022)

Figure 26.            Global Active Pharmaceutical Ingredient Market for NSAIDs, Market Size (US$ billion) (2016 & 2022)

Figure 27.            Global Active Pharmaceutical Ingredient Market for Other Diseases, Market Size (US$ billion) (2016 & 2022)

Figure 28.            Global Active Pharmaceutical Ingredient Market, Segment Share (%), By Geography (2016 & 2022)

Figure 29.            Active Pharmaceutical Ingredient Market in North America, Market Size (US$ billion) (2014 – 2022)

Figure 30.            Active Pharmaceutical Ingredient Market in North America, Segment Share (%) By Regions, (2016 & 2022)

Figure 31.            Active Pharmaceutical Ingredient Market in North America, Market Size (US$ billion), By Manufacturer, 2016 & 2022

Figure 32.            Active Pharmaceutical Ingredient Market in North America, Market Size (US$ billion), By Synthesis (2016 & 2022)

Figure 33.            Active Pharmaceutical Ingredient Market in North America, Market Size (US$ billion), By Drug Type (2016 & 2022)

Figure 34.            Active Pharmaceutical Ingredient Market in North America, Market Size (US$ billion), By Classification (2016 & 2022)

Figure 35.            Active Pharmaceutical Ingredient Market in North America, Market Size (US$ billion), By Therapeutic Area (2016 & 2022)

Figure 36.            Active Pharmaceutical Ingredient Market in Europe; Market Size (US$ billion) (2014 – 2022)

Figure 37.            Active Pharmaceutical Ingredient Market in Europe, Segment Share (%) By Regions, (2016 & 2022)

Figure 38.            Active Pharmaceutical Ingredient Market in Europe, Market Size (US$ billion), By Manufacturer (2016 & 2022)

Figure 39.            Active Pharmaceutical Ingredient Market in Europe, Market Size (US$ billion), By Synthesis (2016 & 2022)

Figure 40.            Active Pharmaceutical Ingredient Market in Europe, Market Size (US$ billion), By Drug Type (2016 & 2022)

Figure 41.            Active Pharmaceutical Ingredient Market in Europe, Market Size (US$ billion), By Classification (2016 & 2022)

Figure 42.            Active Pharmaceutical Ingredient Market in Europe, Market Size (US$ billion), By Therapeutic Area (2016 & 2022)

Figure 43.            Active Pharmaceutical Ingredient Market in Asia-Pacific, Market Size (US$ billion) (2014 – 2022)

Figure 44.            Active Pharmaceutical Ingredient Market in Asia-Pacific, Segment Share (%) By Regions, (2016 & 2022)

Figure 45.            Active Pharmaceutical Ingredient Market in Asia-Pacific, Market Size (US$ billion), By Manufacturer (2016 & 2022)

Figure 46.            Active Pharmaceutical Ingredient Market in Asia-Pacific, Market Size (US$ billion), By Synthesis (2016 & 2022)

Figure 47.            Active Pharmaceutical Ingredient Market in Asia-Pacific, Market Size (US$ billion), By Drug Type (2016 & 2022)

Figure 48.            Active Pharmaceutical Ingredient Market in Asia-Pacific, Market Size (US$ billion), By Classification (2016 & 2022)

Figure 49.            Active Pharmaceutical Ingredient Market in Asia-Pacific, Market Size (US$ billion), By Therapeutic Area (2016 & 2022)

Figure 50.            Active Pharmaceutical Ingredient Market in Rest of the World, Market Size (US$ billion) (2014 – 2022)

Figure 51.            Active Pharmaceutical Ingredient Market in Rest of the World, Segment Share (%) By Regions, (2016 & 2022)

Figure 52.            Active Pharmaceutical Ingredient Market in Rest of the World, Market Size (US$ billion), By Manufacturer (2016 & 2022)

Figure 53.            Active Pharmaceutical Ingredient Market in Rest of the World, Market Size (US$ billion), By Synthesis (2016 & 2022)

Figure 54.            Active Pharmaceutical Ingredient Market in Rest of the World, Market Size (US$ billion), By Drug Type (2016 & 2022)

Figure 55.            Active Pharmaceutical Ingredient Market in Rest of the World, Market Size (US$ billion), By Classification (2016 & 2022)

Figure 56.            Active Pharmaceutical Ingredient Market in Rest of the World; Market Size (US$ billion), By Therapeutic Area (2016 & 2022)

Figure 57.            Market Positioning of Major Players (2015)

Please submit your enquiry below so our representative can get in touch with you
*
*
*
*
*
*
*

USA - CANADA TOLL FREE
+1-800-213-5170
EMAIL
sales@scalarmarketresearch.com

Benefits of Buying From Scalar

  • Unparalleled Expertise

    Our industry experts hold inimitable know-how across wide range of industry verticals

  • Assured Quality

    We deliver high-quality, real-time and data-driven industry insights to our clients

  • 24x7 Analyst Support

    We offer pre-purchase and post-purchase support from our industry experts

  • Privacy & Security

    All your personal information and confidential details are safe and secure with us